chitosan has been researched along with Ureteral Obstruction in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, X; Hou, Y; Piao, JG; Sun, J; Wei, Y; Xu, Z; Yao, W; Zhang, K; Zhang, Q; Zhu, L | 1 |
| Geng, Z; Han, Y; Li, H; Wu, J; Xiong, Q; Xu, Y; Xu, Z; Zhou, J | 1 |
| Cheema, MU; Frøkiær, J; Gao, S; Kjems, J; Nilsson, L; Nørregaard, R; Wang, Y; Yang, C | 1 |
| Hu, J; Li, A; Li, M; Tan, L; Tang, L | 1 |
4 other study(ies) available for chitosan and Ureteral Obstruction
| Article | Year |
|---|---|
Deoxycholic acid-chitosan coated liposomes combined with in situ colonic gel enhances renal fibrosis therapy of emodin.
Topics: Animals; Caco-2 Cells; Chitosan; Deoxycholic Acid; DNA, Ribosomal; Dysbiosis; Emodin; Female; Fibrosis; Humans; Immunoglobulin E; Kidney Diseases; Liposomes; Male; Rats; Rheum; Ureteral Obstruction | 2022 |
Chitosan oligosaccharide alleviates renal fibrosis through reducing oxidative stress damage and regulating TGF-β1/Smads pathway.
Topics: Animals; Chitosan; Fibrosis; Fosinopril; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred BALB C; Oligosaccharides; Oxidative Stress; Renal Insufficiency, Chronic; Transforming Growth Factor beta1; Ureteral Obstruction | 2022 |
Chitosan/siRNA nanoparticles targeting cyclooxygenase type 2 attenuate unilateral ureteral obstruction-induced kidney injury in mice.
Topics: Acute Kidney Injury; Animals; Cell Line; Chitosan; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Histocytochemistry; Immunohistochemistry; Macrophages; Male; Mice; Microscopy, Confocal; Nanoparticles; Optical Imaging; RNA, Small Interfering; Treatment Outcome; Ureteral Obstruction | 2015 |
Hydrosoluble 50% N-acetylation-thiolated chitosan complex with cobalt as a pH-responsive renal fibrosis targeting drugs.
Topics: Acetylation; Animals; Biocompatible Materials; Cell Line; Chitosan; Cobalt; Drug Delivery Systems; Drug Liberation; Fibrosis; Humans; Hydrogen-Ion Concentration; Kidney; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Nanoparticles; Rats; Solubility; Sulfhydryl Compounds; Ureteral Obstruction | 2016 |